DERIVATIVES OF BETULIN

DERIVATIVES OF BETULIN

The present invention relates to compounds characterized by having a structure according to the following Formula I: , or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TANG, JUN, MARTIN, MICHAEL TOLAR, HATCHER, MARK ANDREW, TABET, ALIE AMINE, JOHNS, BRIAN ALVIN
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TANG, JUN
MARTIN, MICHAEL TOLAR
HATCHER, MARK ANDREW
TABET, ALIE AMINE
JOHNS, BRIAN ALVIN
description The present invention relates to compounds characterized by having a structure according to the following Formula I: , or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201404135B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201404135B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201404135B3</originalsourceid><addsrcrecordid>eNrjZBBzcQ3yDHMM8QxzDVbwd1Nwcg0J9fH042FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgaGJgYmhsamTsbEqAEAuKUfKQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVATIVES OF BETULIN</title><source>esp@cenet</source><creator>TANG, JUN ; MARTIN, MICHAEL TOLAR ; HATCHER, MARK ANDREW ; TABET, ALIE AMINE ; JOHNS, BRIAN ALVIN</creator><creatorcontrib>TANG, JUN ; MARTIN, MICHAEL TOLAR ; HATCHER, MARK ANDREW ; TABET, ALIE AMINE ; JOHNS, BRIAN ALVIN</creatorcontrib><description>The present invention relates to compounds characterized by having a structure according to the following Formula I: , or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.</description><language>eng</language><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190424&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201404135B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190424&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201404135B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANG, JUN</creatorcontrib><creatorcontrib>MARTIN, MICHAEL TOLAR</creatorcontrib><creatorcontrib>HATCHER, MARK ANDREW</creatorcontrib><creatorcontrib>TABET, ALIE AMINE</creatorcontrib><creatorcontrib>JOHNS, BRIAN ALVIN</creatorcontrib><title>DERIVATIVES OF BETULIN</title><description>The present invention relates to compounds characterized by having a structure according to the following Formula I: , or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBzcQ3yDHMM8QxzDVbwd1Nwcg0J9fH042FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgaGJgYmhsamTsbEqAEAuKUfKQ</recordid><startdate>20190424</startdate><enddate>20190424</enddate><creator>TANG, JUN</creator><creator>MARTIN, MICHAEL TOLAR</creator><creator>HATCHER, MARK ANDREW</creator><creator>TABET, ALIE AMINE</creator><creator>JOHNS, BRIAN ALVIN</creator><scope>EVB</scope></search><sort><creationdate>20190424</creationdate><title>DERIVATIVES OF BETULIN</title><author>TANG, JUN ; MARTIN, MICHAEL TOLAR ; HATCHER, MARK ANDREW ; TABET, ALIE AMINE ; JOHNS, BRIAN ALVIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201404135B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>TANG, JUN</creatorcontrib><creatorcontrib>MARTIN, MICHAEL TOLAR</creatorcontrib><creatorcontrib>HATCHER, MARK ANDREW</creatorcontrib><creatorcontrib>TABET, ALIE AMINE</creatorcontrib><creatorcontrib>JOHNS, BRIAN ALVIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANG, JUN</au><au>MARTIN, MICHAEL TOLAR</au><au>HATCHER, MARK ANDREW</au><au>TABET, ALIE AMINE</au><au>JOHNS, BRIAN ALVIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVATIVES OF BETULIN</title><date>2019-04-24</date><risdate>2019</risdate><abstract>The present invention relates to compounds characterized by having a structure according to the following Formula I: , or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201404135B
source esp@cenet
title DERIVATIVES OF BETULIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A21%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANG,%20JUN&rft.date=2019-04-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201404135B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true